Curespec

Curespec offers a medical device solution that treats hypertension and chronic kidney disease (CKD). and Europe. https://www.curespec.info/

Curespec,
Reducing Blood Pressure
Curing the Kidneys
A groundbreaking solution that targets chronic kidney disease and hypertension, two critical health challenges affecting over 700 million individuals globally. These conditions drastically reduce the quality of life for those affected. The addressable market for Curespec's solution is substantial, estimated at $16.7 billion across the U.S. Our fully developed and CE-marked product leverages Electro-Hydraulic Acoustic Therapy (eHAT) to transform treatment for hypertension and chronic kidney disease. Curespec's innovative therapy reduces blood pressure and enhances kidney function by rejuvenating renal tissue to promote kidney health. Clinical data reveal that 90% of patients maintain their eGFR levels or lower their blood pressure by at least 5 mmHg. The therapy is noninvasive and painless, ensuring patient safety and comfort. Curespec is a paradigm shift in managing hypertension and chronic kidney disease, bringing hope to millions of individuals worldwide. We invite you to join us in this journey by contacting us or visiting our website.

03/26/2026

A season of renewal and growth 🌱

Just like in nature, meaningful progress often begins in the smallest places.

Restoring flow, strengthening delicate systems, and building from the ground up - this is where true impact starts.

At Curespec, we believe that innovation lies in understanding and renewing the smallest vessels - because that’s where transformation begins.

It’s not just about advancing technology - it’s about enabling healthier systems and sustainable growth. ✨

03/17/2026

Nephrology is entering a new era of nephroprotection.

In recent years, several therapeutic advances have significantly changed how we approach chronic kidney disease (CKD).

SGLT2 inhibitors, non-steroidal mineralocorticoid receptor antagonists, and GLP-1 receptor agonists are expanding our ability to slow disease progression and improve outcomes.

Yet one principle remains fundamental:

Blood pressure control is still one of the most powerful tools to protect kidney function.

The challenge is that kidney damage often begins long before clinical symptoms appear.

This is where earlier detection becomes critical.

As nephrology moves toward earlier intervention and precision medicine, advanced diagnostic tools can help clinicians identify kidney injury sooner—supporting earlier treatment decisions and more effective blood pressure management.

Technologies such as Nephrospec aim to support this shift toward proactive nephroprotection.

03/12/2026

We’re excited that Curespec has been selected to attend the 2026 Mayo ClinicMayo Clinic Cardiology & Radiology Innovation Summit in Rochester, Minnesota.

Looking forward to engaging with the Mayo Clinic community and fellow innovators.

03/05/2026

Excited to share that our article has just been published in Frontiers in Medical Technology!

Our study explores the feasibility and safety of electro-hydraulic acoustic therapy (eHAT) as a non-invasive treatment approach for hypertension in patients with chronic kidney disease.
Proud to be part of this collaboration between Shaare Zedek Medical Center Jerusalem and Mayo Cliniclinic, together with an outstanding team of clinicians and researchers.
Looking forward to the next steps in advancing innovative therapies for hypertension.

Full article link in the comments.

02/18/2026

A New Clinical Tool for Hypertension Management.

NEPHROSPEC™ offers physicians a unique way to help patients reduce blood pressure - safely, comfortably, and with no downtime.
A 20-minute session.

Improved renal microcirculation.
Meaningful BP reduction.

This is what next-generation hypertension care looks like.

02/10/2026

Sometimes the biggest clinical achievement isn’t improvement - it’s stopping the decline.

Avigdor, an 80-year-old engineer and lecturer, faced a steady drop in eGFR that led to a pre-dialysis diagnosis.

After starting treatment with Curespec, the downward trend finally shifted - and even moved slightly upward.

His story is about a curve that changed direction.
Here’s the short testimonial video.

02/04/2026

Great news! 🎉
We’ve received official approval from the Hainan regulatory authority - and the Nephrospec device is now authorized for clinical use.
Another meaningful milestone on our mission to bring advanced therapeutic technologies to patients and make a real impact on their lives. Proud of the team and all our partners on this journey!

01/27/2026

✨ U.S. Pilot Clinical Study – 3 of 5 Patients Treated

We’re excited to share major progress in our U.S. pilot study, conducted in collaboration with NephroNet (Atlanta, USA) - a network of more than 400 nephrologists.

Our study is now fully:
✔ IRB-approved
✔ Classified as a Non-Significant Risk (NSR) device
✔ Designed as a 5-patient pilot study
✔ And we’re pleased to report that all 5 patients are enrolled, with 3 already treated.

This marks an important milestone as we continue moving forward with our mission to advance kidney health through innovative non-invasive technology.

Full steam ahead! 🚀

01/22/2026

✨ A meaningful and exciting milestone – our collaborative NephroNet study received official approval in the United States in January 2026!

We are pleased to share that our clinical research, conducted together with NephroNet focused on evaluating electro-hydraulic acoustic therapy to enhance renal blood flow and glomerular filtration in patients with Stage III diabetic nephropathy, received IRB approval in the U.S. in January 2026.

The approval granted by Advarra IRB, allows us to proceed to the next phase of the study following a thorough review of the protocol, informed consent forms, and required modifications. This represents an important step forward for our joint teams and for the patients who may one day benefit from this innovative approach.

We’re proud to continue advancing a novel therapy with the potential to significantly improve outcomes for individuals living with diabetic kidney disease.

A heartfelt thank you to our research team, our partners at NephroNet, collaborators, and everyone who contributed to reaching this milestone.

Now, we move forward — with commitment, optimism, and purpose.

01/20/2026

What a day at HealthIL Week!
Our booth was buzzing from early morning, and we were truly excited to see how much interest there is in what we’re building at Curespec. So many meaningful conversations, real curiosity, and a long line of visitors throughout the day - thank you to everyone who stopped by.

We’re heading into the next few weeks with a full calendar and plenty of promising leads.
Looking forward to turning these encounters into collaborations that can genuinely move healthcare forward.

A huge thank you to the organizers and partners who made this event possible and all the amazing teams behind the scenes.

Address

203 Perry Parkway Suite #6
Gaithersburg, MD
20877

Website

https://www.curespec.info/

Alerts

Be the first to know and let us send you an email when Curespec posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Curespec:

Shortcuts

Want your practice to be the top-listed Clinic in Gaithersburg?